Private equity (PE) firms have increased their ownership stake across health care sectors in the US. PE’s focus on short-term profitability may decrease the provision of unprofitable services, ...

Pars plana vitrectomy is a safe and effective surgery that is essential in the treatment of a variety of posterior segment ...

In this Healio Video Perspective from the COPHy meeting, José García-Arumí, MD, PhD, summarizes a debate session he co-chaired on scleral buckling vs. vitrectomy in retinal detachment surgery.

Pykus Therapeutics announced it has completed enrollment in its pilot study, PYK-2101-RD00, evaluating PYK-2101, a focal ...

Pykus Therapeutics, Inc. ("Pykus" or the "Company") announced today that it has completed enrollment of its pilot study (PYK-2101-RD001) in Australia. The study is evaluating the use of Pykus' ...

PYK-2101-RD001 is a prospective, multicenter, open-label pilot trial examining the use of PYK-2101 in 11 patients with retinal detachment undergoing pars plana vitrectomy (Figure 1). The objective ...

PYK-2101-RD001 is a prospective, multicenter, open-label pilot trial examining the use of PYK-2101 in 11 patients with retinal detachment undergoing pars plana vitrectomy in Australia. The main ...

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about retinal detachment and pars plana vitrectomy as a treatment. Samuel Alito Comment During Obamacare Supreme Court Hearing Sparks ...

The ideal candidate is a patient with a phakic retinal detachment with a single break in the superior clock hours. Pars plana vitrectomy offers several unique advantages, including relief of all ...